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ABSTRACT
Shigella dysenteriae type 1 causes devastating epidemics in developing countries with high case-fatality rates 
in all age-groups. The aim of the study was to compare host immune responses to epidemic (T2218) and 
endemic strains of S. dysenteriae type 1. Shigellacidal activity of serum from rabbits immunized with epi-
demic or endemic strains, S. dysenteriae type 1-infected patients, and healthy adult controls from Shigella- 
endemic and non-endemic regions was measured. Immunogenic cross-reactivity of antibodies against 
Shigella antigens was evaluated by Western blot analysis. Oxidative burst and phagocytic responses of 
monocytes and neutrophils to selected S. dysenteriae type 1 strains were assessed by flow cytometry. Rabbit 
antisera against epidemic strain were less effective in killing heterologous bacteria compared to endemic 
antisera (p=0.0002). Patients showed an increased serum shigellacidal response after two weeks of onset of 
diarrhoea compared to the acute stage (3-4 days after onset) against their respective homologous strains; 
the response against T2218 and heterologous endemic S. dysenteriae type 1 strains was not significant. The 
serum shigellacidal response against all the S. dysenteriae type 1 strains was similar among healthy controls 
from endemic and non-endemic regions and was comparable with the acute stage response by patients. 
Compared to endemic strains of S. dysenteriae type 1, T2218 was significantly resistant to phagocytosis by 
both monocytes and neutrophils. No obvious differences were obtained in the induction of oxidative burst 
activity and cathelicidin-mediated killing. Cross-reactivity of antibody against antigens present in the epi-
demic and endemic strains showed some differences in protein/peptide complexity and intensity by West-
ern blot analysis. In summary, epidemic T2218 strain was more resistant to antibody-mediated defenses, 
namely phagocytosis and shigellacidal activity, compared to endemic S. dysenteriae type 1 strains. Part of 
this variation may be attributed to the differential complexity of protein/peptide antigens.  
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INTRODUCTION
Shigellosis is a global public-health problem. Ac-
cording to the recent report of the World Health 
Organization on the worldwide burden of shigel-
losis, 90 million cases of diarrhoea due to Shig-
ella occur annually mostly in developing coun-
tries, and an estimated 108,000 deaths per year 
are attributed to Shigella infections (http://www.
who.int/vaccine_research/diseases/diarrhoeal/en/
index6.html # vaccine). Currently, no licensed vac-
cines against Shigella infection exist (1).
Four species of Shigella are responsible for causing 
bacillary dysentery: Shigella dysenteriae, S. flexneri, S. 
sonnei, and S. boydii. Of the four species, S. dysente-
riae type 1 produces the most severe form of dis-
ease with a high mortality rate in young children, 
elderly people, and the malnourished and can be 
associated with various complications (1,2). Since 
the 1960s, S. dysenteriae type 1 is known to be an im-
portant cause of epidemic dysentery in Latin Amer-
ica, Africa, and Asia, including Bangladesh (1,3-6). 
Epidemic shigellosis largely depends on drug re-
sistance (7), variation in Shiga toxin (8), or other 
unknown causes. Studies on differences between Sayem AM et al. Host defense responses to Shigella dysenteriae type 1 strains
JHPN 430
epidemic and circulating endemic strains of Shigella 
are scarce. In one study, the plasmid profile of Shige- 
lla spp. isolated during an outbreak was shown to 
be different from that of endemic isolates (9). An-
other study reported that, during sporadic and out-
break incidences of shigellosis, epidemic variants 
had the most stable plasmids (10). To understand 
the transmission dynamics of Vibrio cholerae during 
epidemics, Merrel et al. showed that increased in-
fectivity of V. cholerae was associated with variable 
expression level of various genes (11). However, till 
date, no studies on comparison between host im-
mune responses to epidemic and endemic Shigella 
isolates have been conducted.
Studies to understand the differences in the host 
immune response to epidemic and endemic Shigella 
strains may eventually aid in designing alternative 
treatment strategies during epidemics and vaccine 
development. Therefore, we aimed to assess the im-
mune responses evoked by epidemic and endemic 
strains of S. dysenteriae type 1 by studying phago-
cytic response and oxidative burst of neutrophils 
and monocytes, serum and LL-37-mediated killing 
of these strains. The difference in immunogenicity 
of these strains was also evaluated by Western blot 
analysis of the whole-cell antigens.
MATERIALS AND METHODS
S. dysenteriae type 1 strains
The epidemic strain T2218 was collected during a 
dysentery epidemic in Teknaf, a coastal area in 
Bangladesh, that caused high mortality among 
children aged less than one year (12). Endemic S. 
dysenteriae type 1 strains isolated from S. dysentetiae 
type 1-infected adult patients (n=8) admitted to the 
Dhaka Hospital of icddr,b enrolled in a previous 
study (13) were used in the present study. Patients 
were empirically treated with pivmecillinam. 
Table 1 shows the different strains that were used 
for various immunological assays. Serum and strain 
from the same source (patient or immunized rab-
bit) were designated as homologous while serum 
and strain isolated from different sources (patient 
or immunized rabbit) were designated as heter-
ologous strain or heterologous serum. The bacte-
rial cultures were stored at -80 °C in Trypticase 
Soy Broth (TSB) (Difco, Spartus, MD) with 15% 
glycerol. Before using in immunological assays, 
isolates were confirmed by biochemical reactions, 
agglutination with specific antiserum, and Séreny 
test. 
Blood and serum samples
Patients with shigellosis were followed for one 
month, and blood samples were collected at differ-
ent intervals after the onset of diarrhoea (3-5, 14-
16, and 30-35 days) (13). For convenience, these 
follow-up days were referred to as days after admis-
sion (day 1, 11, and 30). Blood samples obtained 
from healthy adults (laboratory staff, n=15, aged 
24-30 years) at icddr,b were from Shigella-endemic 
area and from healthy Swedish adults (n=5, aged 
21-56 years) as Shigella non-endemic area (13). 
Preparation of rabbit antisera against epidem-
ic and endemic S. dysenteriae type 1 strains
Permission was obtained from the Animal Ethics 
Committee of icddr,b for raising antisera against 
the bacterial strains. The S. dysenteriae type 1 epi-
demic strain (T2218) and one endemic S. dysenteri-
ae type 1 strain (191316) were used for immunizing 
rabbits. New Zealand White rabbits (n=3 for each 
strain) were immunized subcutaneously and in-
tramuscularly five times with formalin-killed Shige- 
lla suspension at two-day intervals using 5-10x107 
colony-forming units per time point. Seven to 10 
days after the end of the immunization protocol, 
venous blood was obtained to collect serum, and 
antibody levels were tested by standard agglutina-
tion test (14).
Serum shigellacidal assay
The serum shigellacidal assay was carried out as des- 
cribed earlier (14). In brief, bacterial strains in Mue- 
ller Hinton Broth (MHB) (Difco) (1x103 cfu/mL), 
guinea pig complement (Sigma-Aldrich, St Louis, 
USA), and two-fold serially-diluted heat-inactivated 
serum samples (starting dilution for patient sera 
1:10; for rabbit sera 1:1) were incubated in a shaker 
incubator (200 rpm) at 37 °C for 16 hours. The op-
tical density was measured at 595 nm. The shigel-
lacidal antibody titre was defined as the reciprocal 
of the highest serum dilution to yield >95% reduc-
tion of optical density compared to control wells 
without serum. The various combinations of rabbit 
antisera with bacteria are given in Table 2.
Fluorescence labelling of Shigella 
Both 191316 and T2218 strains were labelled with 
fluorescein isothiocyanate (FITC) (Sigma) as des- 
cribed previously (15,16) with minor modifications. 
FITC (1 mg/mL) was added to bacteria (1x108/mL), 
incubated at room temperature for 25 minutes in a 
shaker, washed with phosphate buffer saline (PBS), 
fixed with 1% formaldehyde in dark for 30 minutes, 
and after washing, the labelled Shigella was kept at 
4 0C. For the in vitro assays, freshly-labelled bacteria 
were used.
Phagocytosis and oxidative burst activity of 
monocytes and granulocytes by flow cytometry
Phagocytic activity was measured as previously Host defense responses to Shigella dysenteriae type 1 strains Sayem AM et al.
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Table 1. List of isolates used
Isolate  Place of isolation Year Assays
Epidemic
T2218
 Teknaf, Bangladesh 1985 All 
Endemic
191316    Dhaka Hospital, icddr,b 2002 Phagocytosis, oxidative burst, raising 
antisera, and Western blot analysis
Endemic
192789
179370
179268
178042
184223
175560
191309
191325
  Dhaka Hospital, icddr,b 2002 Shigellacidal assay with sera of patients
Endemic
  Dhaka Hospital, icddr,b 2002 Shigellacidal assay with healthy adult 
and rabbit antisera
191316 
191309 
191325
described (17). Heparinized blood was incubated 
first with FITC-labelled Shigella (1x107) (endemic S. 
dysenteriae type 1 191316 or T2218 strain) for 30 
minutes at 37 0C in dark and then with ethidium 
bromide (EtBr) (Invitrogen Corporation; Carlsbad, 
CA) in ice. After washing, RBC was lysed by am-
monium  chloride  solution,  and  fluorescence  in-
tensity was measured by flow cytometry using the 
CELLQUEST software. Cells were identified by For-
ward scatter-Side scatter gating, and green FITC 
signals were detected in the FL-1 (fluorochrome 
1) detector functioning at 480 nm detecting green 
fluorescence. 
Oxidative burst activity was assessed by measuring 
the intensity of the redox indicator dye Di-chloro-
fluorescence (DCF) (15). The intensity of DCF is 
an indirect measure of the level of reactive oxygen 
species (ROS) generated in a cell following activa-
tion. Heparinized blood was incubated first with 
DCFH-DA (Sigma) and then with 1x107 Shigella 
(endemic S. dysenteriae type 1 191316 or T2218 
strain) for 30 minutes each at 37 0C in dark. After 
lysing RBC with ammonium chloride, fluorescence 
intensity was assessed as above. DCF signals were 
detected in the FL-1 detector. 
Controls included granulocytes in PBS without la-
belled bacteria and bacteria without granulocytes. 
In all the cases, the geometric mean fluorescence 
intensity (MFI) of the gated cell populations was 
estimated. Each assay was done in triplicates using 
eight different blood donors.
Table 2. Comparison of shigellacidal activity of rabbit antisera against epidemic and endemic Shigella 
dysenteriae type 1 strains in various combinations by Kaplan-Meier survival curve analysis
Combination 95% CI Log-rank test p value
EnSd1 + anti-EnSd1 0.19-0.52
EpSd1 + anti-EpSd1 0.22-0.64 1.17 0.28
EnSd1 + anti-EnSd1 0.19-0.52
EnSd1 + anti-EpSd1 1.0-1.0 20.1 0.00001
EpSd1 + anti-EnSd1 0.22-0.64
EpSd1 + anti-EpSd1 0.22-0.64 0 1.0
EnSd1 + anti-EpSd1 1.0-1.0
EpSd1 + anti-EpSd1 0.22-0.64 14.25 0.0002
EnSd1 + anti-EnSd1 0.19-0.52
EpSd1 + anti-EnSd1 0.22-0.64 1.17 0.28
Data (1/dilution of antisera) given as 95% CI of means. Data shown here are for one endemic strain only 
(#191316). CI=Confidence interval; EnSd1=Endemic Shigella dysenteriae type 1 strain; EpSd1=Epidemic 
S. dysenteriae type 1 strain; anti-EnSd1=Rabbit antisera against endemic S. dysenteriae type 1; anti-
EpSd1 Rabbit antisera against epidemic S. dysenteriae type 1Sayem AM et al. Host defense responses to Shigella dysenteriae type 1 strains
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Fig. 1. Serum shigellacidal titre of Shigella-
infected patients (day 1, 11, and 30, 
n=8), endemic healthy adult controls 
(EHC, n=15), and non-endemic healthy 
adult controls from Sweden (SC, n=5) 
against endemic homologous (closed 
circles), endemic heterologous (open 
circle), and epidemic strain (closed tri-
angles1 of Shigella dysenteriae type 1
Data are expressed as mean±SEM. *Represents 
p=0.05; EHC=Endemic healthy adult controls; 
SC=Non-endemic healthy adult controls from 
Sweden; SEM=Standard error of mean
Cathelicidin-mediated killing
The killing of Shigella spp. with CAP-18 has been 
described earlier (18). Bacterial suspension (2x102 
cfus) was used with different dilutions of LL-37 
(human cathelicidin) (Innovagen, Lund, Sweden) 
or CAP-18 (rabbit cathelicidin) (Innovagen). Con-
trol wells contained MHB alone, bacteria in MHB, 
and LL-37 (or CAP-18) in MHB. From individual 
wells, the mixture was plated on MacConkey agar 
for bacterial colony counts.
Western blot
Epidemic and endemic S. dysenteriae type 1 cells 
(1x109) were sonicated to lyse the bacteria, and 
complete killing was verified by plating on agar 
plate. Sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE) was performed 
at 100 V, 200 mA, and at room temperature to 
separate the lysates. About 2.5 µg of bacterial lysate 
was mixed with sample buffer (0.0625 M Tris, pH 
6·8), boiled for two minutes at 95 °C, loaded on 
12% SDS polyacrylamide gel and electrophoresed. 
Biotinylated molecular weight marker (SDS-PAGE 
standards, high-range BioRad) was included. Sam-
ples were pretreated with proteinase K (10 mg/
mL, Sigma-Aldrich for 2-2:30 hours) to digest the 
proteins/peptides and confirm that the bands ob-
tained were truly protein and not lipopolysaccha-
ride (LPS). Separated proteins/peptides were blot-
ted onto nitrocellulose membrane (Osmonics Inc, 
Cole-Parmer). Blots were blocked in 1% bovine se-
rum albumin-PBS, washed with 0.1% BSA-PBS, the 
membrane was incubated sequentially with pri-
mary antisera (1:150) (pooled endemic or epidemic 
rabbit antisera), secondary antibody anti-rabbit IgG 
(1:200 in 0.1% BSA in PBS-Tween), and streptavi-
din conjugated with horseradish peroxidase. Mem-
brane was developed with 4-chloro-naphthol to 
visualize immunoreactivity.
Statistical analysis
The SigmaStat software (version 3.1) (Systat Soft-
ware, Inc., Point Richmond, CA) and the SPSS soft- 
ware for Windows (version 12.0) (SPSS, Inc, Chi-
cago, IL, USA) were used for analysis of data. Stu-
dent’s t-test or Mann-Whitney rank sum test was 
used for comparing the immune responses (phago-
cytosis, oxidative burst, and cathelicidin-mediated 
killing) between endemic and epidemic strains. 
Shigellacidal activities of different antisera were 
compared by Kaplan-Meier survival curves using 
the log-rank (Mantel-Cox) test. One-way analysis 
of variance (ANOVA) was used for analyzing the se-
rum shigellacidal responses among Shigella-infect-
ed patient samples over days. Data are expressed as 
mean±sandard error of mean (SEM). P value was 
significant when ≤0.05.
RESULTS
Serum shigellacidal response
Shigellacidal assays were performed to see whether 
the epidemic and endemic strains had differ-
ent susceptibility to antibody-mediated killing. 
The shigellacidal response of patient sera against 
the respective homologous S. dysenteriae type 1 
strains was significantly higher on day 11 com-
pared to day 1 (p=0.05) (Fig. 1); the response re-
duced on day 30 but still remained higher than 
day 1. The serum shigellacidal response against 
the heterologous strains had a similar trend but 
the difference was not significant (Fig. 1). The se-
rum shigellacidal responses of EHC (n=15) and SC 
(n=5) against the epidemic strain (T2281) and 
the three endemic strains were comparable.
In the Kaplan-Meier survival plot analysis, rab-
bit antisera raised with endemic S. dysenteriae Host defense responses to Shigella dysenteriae type 1 strains Sayem AM et al.
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Fig. 2. Comparison by Kaplan-Meier analysis of shigellacidal response of rabbit anti-EnSd1 
(191316) and anti-Epsd1 (T2218) antisera against 191316 and T2218 strains in different 
combinations
At least 3 replicate assays were done for conﬁrmation and statistical convenience; CFU=Colony-
forming unit; EnSd1=Endemic Shigella dysenteriae type 1; EpSd1=Epidemic S. dysenteriae type 1
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type  1 showed shigellacidal activity at 1:20 dilu-
tion against homologous and at 1:10 dilution 
against heterologous endemic strains (n=3) and the 
epidemic strain (Fig. 2 and Table 2). Epidemic an-
tisera showed shigellacidal activity at 1:10 dilution 
against the homologous epidemic strain but could 
only kill the endemic strains when used in neat 
concentration (Table 2). Data are shown in Fig. 2 
and Table 2 for one endemic strain only (191316).
Phagocytic responses and oxidative burst in 
monocytes and granulocytes
To understand whether there were differences in 
susceptibility of epidemic and endemic Shigella str- 
ains to innate cellular responses of granulocytes, 
phagocytosis  and  oxidative  burst  responses  were 
studied. Compared to the endemic 191316 strains, 
the epidemic T2218 strain showed significantly 
lower susceptibility to phagocytosis by both 
neutrophils (p<0.01) and monocytes (p<0.01) (Fig. 
3A). There was no apparent difference between 
the epidemic and the endemic strains in inducing 
oxidative burst response in both monocytes and 
granulocytes (Fig. 3B).
In vitro killing by cathelicidin
Cathelicidin, a family of classical antimicrobial 
peptides, kills bacteria by upsetting the integrity 
of bacterial membrane (19). To check whether 
cathelicidin exhibited differences in killing of the 
epidemic and endemic strains due to any outer-
membrane structural differences, in vitro killing 
experiment was conducted using human catheli-
cidin LL-37 and rabbit cathelicidin CAP-18. Both 
epidemic strain (T2218) and endemic strains (n=3) 
were completely killed by LL-37 at a concentration 
of 5.55 μM (minimal inhibitory concentration). 
Similarly, no differences were found for CAP-18-
mediated killing where the minimal inhibitory 
concentration was 0.9 μM against both epidemic 
and endemic strains.
Western blot analysis
To study if the observed differences in immune 
responses evoked by the epidemic and endemic 
strains is linked to variations in immune recogni-
tion of protein antigens between the strains, West-
ern blot analysis was conducted. Results of analysis 
revealed that the endemic (191316) and epidemic 
(T2218) strains differed in protein/peptide complex-
ity and in intensity of some protein/peptide bands. 
Both endemic and epidemic antisera recogni- 
zed three antigens (30-35 kd) in the epidemic strain Sayem AM et al. Host defense responses to Shigella dysenteriae type 1 strains
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Fig. 4. Western blot analysis of sonicated Shige-
la bacterial lysate using rabbit antisera rai-
sed against endemic (EnSd1, 191316) and 
epidemic (EpSd1, T2218) strains 
Lane 2 (EnSd1 lysate) and 3 (EpSd1 lysate) were 
detected by pooled endemic antisera (α EnSd1); 
Lane 4 (EnSd1 lysate) and Lane 5 (EpSd1 lysate) 
were detected by pooled epidemic antisera (α 
EpSd1). Lane 1 contains marker. The difference  
between epidemic (T2218) and endemic (191316
strains is evident in at least  four protein bands 
marked by arrows; EnSd1=Endemic Shigella dys-
enteriae type 1; EpSd1=Epidemic S. dysenteriae 
type 1
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EnSd1 with α EnSd1
EnSdl with α EnSdl
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(Lane 3 and 5 of Fig. 4) but not in the endemic 
strain. Conversely, both antisera could detect one 
antigen (~103 kd) only in the endemic strain (Lane 
2 and 4, Fig. 4). Proteinase K treatment of the an-
tigen lysate showed no bands in the blot reflecting 
that these were protein/peptide bands only.
DISCUSSION
The results of the study showed that the epidemic 
strain of S. dysenteriae type 1 mounted lower levels 
of shigellacidal serum antibodies and was more re-
sistant to phagocytosis by neutrophils and mono-
cytes compared to the endemic strains. Some dif-
ference in immunoreactive protein/peptide bands, 
both in term of complexity and intensity between 
the epidemic T2218 strain and the endemic 191316 
strains, was obvious as detected by Western blot 
analysis. Interestingly, cathelicidin-mediated killing 
of the epidemic and endemic strains showed no 
difference.
A major obstacle in developing an appropriate vac-
cine against Shigella species is the production of 
protective neutralizing antibodies after immuniza-
tion that are serotype-specific (20). In line with this, 
we found that the bactericidal capacity of serum 
from S. dysenteriae type 1-infected patients against 
homologous Shigella increased significantly after 
two weeks that declined to the control levels after a 
month. This was similar to antibody-secreting cell 
(ASC) response after natural shigellosis or vaccina-
tion (21) while Shigella LPS-specific IgG responses 
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Data are expressed as mean±SEM; DCF=Di-
chloro-ﬂuorescence; EnSd1=Endemic S. dys-
enteriae type 1; EpSd1=Epidemic S. dysente-
riae type 1; FITC=Fluorescein isothiocyanate; 
MFI=Mean ﬂuorescence intensity; SEM=Stan-
dard error of mean
Fig. 3. Endemic and epidemic Shigella dysente-
riae type 1 strain induced (A) phagocyto-
sis responses in monocytes and granulo-
cytes (n=8) against FITC-labelled Shige-
lla measured by ﬂow cytometry and (B) 
oxidative burst responses in monocytes 
and granulocytes (n=8) measured by the 
MFI of DCFHost defense responses to Shigella dysenteriae type 1 strains Sayem AM et al.
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remained elevated in serum for more than six 
months (22). However, the shigellacidal immune 
function of patients’ antisera was lower against the 
heterologous S. dysenteriae type 1 strains and the ep-
idemic strain (T2218), although all these strains are 
of the same serotype. Notably, the healthy subjects 
from Shigella-endemic and non-endemic regions 
did not show significant differences in shigellacidal 
response against the epidemic and endemic strains. 
This result further confirms that adaptive immune 
function in shigellosis is not long lasting and may 
be one of the reasons why epidemics due to Shigella 
occur successfully in endemic regions in primed 
population with high baseline IgG antibody titres 
(22,23).
In rabbits, the shigellacidal antibody response 
evoked by the epidemic strain was less efficient 
compared to the endemic strains in killing the 
strain itself (T2218) and the heterologous en-
demic strains. This outcome may result from 
variations in the immunogenicity, suboptimal 
exposure of peptide antigens of Shigella strains 
and in the affinity and avidity of the specific neu-
tralizing antibodies. One limitation of this study 
was that the unavailability of patient’s serum in-
fected with epidemic strain to compare with en-
demic patient antisera.
Phagocytes are the effectors of the innate immune 
system. Human phagocytes, particularly neu-
trophils, can ingest both opsonized and non-op-
sonized Shigella. Interaction of a phagocyte with 
a foreign particle ultimately triggers the oxidant 
cascade that causes structural alterations in the 
invasive pathogens, irrespective of the type of mi-
crobes. There is also a role of opsonization in oxida-
tive burst pathway (24). The rate of phagocytosis 
of opsonized endemic strain increased by approxi-
mately two-fold compared to opsonized epidemic 
strain. However, we did not find any significant 
differences in oxidative burst function. The find-
ings indicate greater resistance of epidemic strain to 
phagocytosis compared to endemic strain but not 
to oxidative burst-mediated killing. The observed 
difference in the internalization of the epidemic 
and endemic strains by blood phagocytes might be 
explained by the differences in antibody-mediated 
opsonization of the strains. 
Western blot analysis of bacterial lysate using rab-
bit antisera, raised against the endemic or epidemic 
strains, revealed some differences in protein/pep-
tide band sizes and also in band intensity between 
the endemic and the epidemic strains (Fig. 4). The 
differences in protein/peptide bands clearly indi-
cate the variation in immunogenic properties of the 
two strains. This variation may give the epidemic 
strain an edge above the endemic strains in evok-
ing pro-inflammatory responses and severity of the 
disease during epidemics. For example, the ability 
of bacterial protiens, such as S. flexneri porins to ac-
tivate Toll-like receptors (TLR-2), thereby stimulat-
ing the production and release of proinflammatory 
cytokines, adhesion molecules, and nitric oxide, 
suggests a possible role of these bacterial proteins in 
inflammation (25). Many proteins of the epidemic 
S. dysenteriae type 1, such as type III secretion sys-
tem, energyy metabolism, acid resistance may also 
play a significant role in the increased virulence of 
the epidemic S. dysenteriae type 1 strain (26). 
Antimicrobial peptides of the cathelicidin family 
are cationic and amphipathic molecules that bind 
to the negatively-charged cell membrane of bacteria 
and kill them by disruption of bacterial membrane 
integrity possibly through the formation of toroidal 
peptide-lipid pores (19). LL-37 binds strongly in a 
dose-dependent fashion to LPS from gram-negative 
bacteria or to peptidoglycan, lipoteichoic acid, and 
wall teichoic acid from gram-positive Staphylococcus 
aureus (27). Thus, the lipid components of the bac-
terial cell envelope seem to play a major role in the 
antimicrobial activity of LL-37 where surface pro-
teins may not play a significant role. In our study, 
in vitro shigellacidal concentration of cathelicidin 
(LL-37 or CAP18) was the same for both epidemic 
and endemic strains, indicating similarities in net 
charge and hydrophobicity of the outer membrane 
of both the strains.
Conclusions 
The findings of the study suggest that the epidemic 
Shigella strain is more resistant to antibody-mediat-
ed killing and ingestion by phagocytes compared to 
the endemic strains. The difference in protein/pep-
tide antigens may partially reflect the difference in 
immune responses evoked by the epidemic and en-
demic strains. More detailed studies of the varying 
protein antigens among strains will resolve many 
unidentified mechanisms influencing the immune 
responses, specially the levels and types of antibod-
ies. Reduced susceptibility to antibody-dependent 
killing by the hypervirulent Shigella bacteria may 
be one of the strategies to escape host defense and 
cause epidemics.
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